July 2005  
Cover Page
Articles
Un-Tapped Executive Benefits in the Small Business Markets
Case Study: Skin Cancer
Tools of the Trade
Life Needs Analysis
Human Life Value
Agent Sales Corner
Links
ABSGO.COM
AM Best Company
The Weather Channel
Associated Press
Case Study: Skin Cancer
by Prudential

Skin cancer is the most common form of human cancer with over 600,000 new cases/year. One in six Americans will develop
skin cancer in their lifetime. The mo st common cause of skin cancer is overexposure to the sun. 90% of all skin cancers
occur on sun exposed skin. People most likely to get skin cancer have:

  • A family history of melanoma
  • Fair skin which burns easily and tans poorly
  • Red or blonde hair
  • Blistering sunburns in childhood or adolescence
  • Dysplastic nevi (atypical moles)

There are three types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and malignant melanoma.

Basal cell carcinoma is the most common type and has the best prognosis. It usually looks like a small pearly nodule that slowly grows, if left untreated. Lesions are surgically removed. Recurrences are common, but it rarely metastasizes (spreads to distant sites). Localized basal cell cancers, after excision, are non-rated.
 
Squamous cell carcinoma can be a nodule or a reddish patch. Recurrences are also common and 3 - 10% will metastasize. Localized squamous cell cancers, after surgical excision, are non-rated.

Malignant melanoma is the least common, but most serious and can start as a mole. Lesions are surgically removed. Staging is determined by the level of invasion (Clark level) or vertical thickness (Breslow Scale).

Clark Level       Breslow Scale
I (in situ)    in situ
II (invades papillary dermis)    <0.75mm
III (invades to papillary-reticular junction)  0.75 - 1.5mm
IV (invades reticular dermis) 1.51 - 4.0mm
V (invades subcutaneous tissue)   > 4.0mm
 
The rating for malignant melanoma ranges from no rating for in situ cancers to postpone for 4 years for Clark levels IV and V. For example, first year ratings per Clark level are: in situ...non-rated, Level II...$5-7.50x5*, Level III...$7.50-10x6*, Levels IV & V...Postpone. A history of metastatic melanoma would be declined.

*The lower rating applies if lesion excised was located on the arm or leg; the higher rating is for lesions excised from the head, neck, trunk, hands or feet.


Company Spotlight
Empire General Fire Sale
 
Monthly Survey

Are you interested in participating in our upcoming Impaired Risk Webinar?

Yes, I am interested

Yes, but not at this time

I am not interested

 [See Results]
Subscribe/Remove

Enter your email address in the box below to receive an email each time we post a new issue of our newsletter:


Add Remove
Send as HTML
 

LETTERS

There are no letters for this article. To post your own letter, click Post Letter.

[POST LETTER]
Powered by IMN